Form D — Alessa Therapeutics, Inc.
0001771653-25-000005 · filed May 1, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $31,616,096
- Reported amount sold
- $25,376,457
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Alessa Therapeutics, Inc.
- CIK
- 1771653
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 930 BRITTAN AVENUE
SAN CARLOS, CA 94070 - Phone
- 650-223-5912
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Cam Gallagher · Executive OfficerSan Carlos, CA Find on LinkedIn ↗
-
Richard Lim · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Annie Mitsak · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Douglas Crawford · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Pamela Munster · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Steve Tregay · DirectorSan Carlos, CA Find on LinkedIn ↗
-
Zachary Collins · Executive OfficerSan Carlos, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗